Suk Jin Kim

39PUBLICATIONS
93CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyRespiratory diseasesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 29, 2026
Circulating CD20-positive extracellular vesicles impair rituximab efficacy and predict outcomes in diffuse large B-cell lymphoma.

|Jun 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

|Feb 10, 2026
Complementary Roles of Next-Generation Flow and Next-Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma.

Min-Seung Park, Dae Jin Lim, Hee-Jin Kim

|Feb 02, 2026
Long-term outcomes of 40 Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTL.

Sang Eun Yoon, Dongryul Oh, Gwanghui Ryu

|Dec 10, 2025
Real-World Efficacy of Tafamidis in Korean ATTR-CM Patients: A Retrospective Observational Strain Analysis.

Heayoung Shin, Kina Jeon, Darae Kim

|Dec 09, 2025
Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma.

Sang Eun Yoon, Woorim Kang, Junhun Cho

Pageof 7

Frequent Collaborators

12 joint publications

Sang Eun Yoon

8 joint publications

Kihyun Kim

6 joint publications

Won Seog Kim

6 joint publications

Duck Cho